Articles tagged with Cancer Patients
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study of cancer patient-clinician encounters found that only a small percentage of patients requested clinically inappropriate tests or treatments. Most requests were for imaging studies, laboratory tests, or palliative care interventions, with few requesting chemotherapy or proton beam therapy.
Research presented at the American Stroke Association's International Stroke Conference 2015 found that stroke survivors have a higher annual rate of age-adjusted cancer incidence compared to the general population. Additionally, stroke survivors who develop cancer are more than three times likely to die compared to those without cancer.
Patients who preferred physician-controlled decisions had lower reported quality of care compared to those with shared decision-making. Patients' reports about the quality of their care are increasingly important health care performance measures.
Researchers at A*STAR's Genome Institute of Singapore have developed an expert system called OncoIMPACT that combines cancer omics data with machine learning models to predict treatment targets. The system has been applied to over a thousand cancers, including melanomas and ovarian cancers, and shows promise for personalized medicine.
Researchers found that certain HPV+ oropharyngeal cancer patients can survive for over two years without further disease after intensive treatment. The study identified key factors contributing to the survival advantage, including cancer sensitivity to radiotherapy and chemotherapy.
Researchers have developed a revolutionary model to study hematopoiesis in living organisms, revealing that at least one-third of blood stem cells produce differentiated progenitor cells. The study also shows that mature blood cells are supplied by first progenitor cells that regenerate themselves over time.
A new radiotracer has been developed to accurately identify the sentinel node in head and neck squamous cell carcinoma, reducing the need for extensive surgery. The study shows a high detection rate and low false negative rate for SNs, facilitating accurate prediction of cancer spread.
A study of 5,050 patient-clinician encounters found that only 1% were clinically inappropriate, and physicians complied with fewer than 1 in 10 requests. The findings challenge the myth of the 'demanding patient' and suggest a need to redirect attention from unnecessary costs.
New research suggests that cancer false alarms could lead to patients delaying symptom checks due to a lack of support. A systematic review found that over-reassurance and under-support can discourage patients from seeking help for new or recurrent symptoms.
A study found that young adult survivors (18-39) report higher distress levels than older survivors, despite similar time since treatment completion. Fear of cancer recurrence and financial burden were key predictors of elevated distress in these young adults.
Researchers found higher proportions of women and young adults dying of mesothelioma in two counties encompassing Las Vegas, suggesting naturally occurring mineral fibers are a contributing source. The study highlights the need for more research to reduce exposure.
A new $10 million research program aims to investigate and experimentally validate nutritional interventions, develop reliable DNA tests, and introduce new cancer prevention strategies to the general public and policymakers. Research suggests that more than half of all colon cancers can be prevented through dietary and behavioral inter...
Researchers at the University of Minnesota Academic Health Center have developed a new reporter system to study bone regeneration potential in human embryonic stem cells. The system allows for better monitoring of cell properties and may lead to the creation of new therapies for diseases such as leukemia or genetic blood disorders.
The center aims to provide clinical care and research using heavy particles for innovative new cancer treatments, offering a more potent and precise therapy than conventional options. The project is expected to create 130 high-level jobs and generate over $600 million in economic impact for Texas.
A recent study by UT Southwestern Medical Center found that patients with a prior cancer diagnosis have similar clinical outcomes to those without a history of cancer. The researchers studied over 102,000 patients and found that these patients had better overall survival and lung cancer-specific survival rates.
A new study from Columbia University Medical Center has found that a drug targeting the fused protein in glioblastoma may lead to significant clinical improvement and tumor reduction. The research suggests that developing a more precise drug could result in better treatment outcomes for patients with brain cancer.
A recent study found that nearly a third of women with N2/N3 breast cancer did not receive post-mastectomy radiation therapy (PMRT), which is the standard of care for this patient group. The study evaluated over 57,000 cases and found that socioeconomic factors did not influence PMRT receipt.
A new study has identified eight specific physical signs associated with imminent death in cancer patients, including non-reactive pupils and drooping of the nasolabial fold. These signs can help healthcare professionals make a diagnosis of impending death, allowing for more informed decisions about treatment and care.
A study by MD Anderson researchers identified eight physical and cognitive signs associated with imminent death in cancer patients. These signs include nonreactive pupils, decreased response to verbal and visual stimuli, and upper gastrointestinal bleeding, which could help clinicians communicate with patients and families, as well as ...
Researchers at NIH identified chromothripsis as the reason for a patient's spontaneous cure of WHIM syndrome. The study showed that a random deletion of mutant CXCR4 gene in stem cells led to normal neutrophil function.
Two-thirds of primary care health professionals want to widen exemption criteria for long-term conditions and lower or abolish charges altogether. The current system is seen as a barrier that prevents some people from receiving necessary prescriptions.
A new Special Issue from ecancermedicalscience tackles fertility-sparing cancer treatments, collecting latest research on preserving fertility in breast, cervical and ovarian cancers. Fertility-sparing treatments balance patient's wishes with oncological outcomes.
A new forecast from Cancer Research UK suggests that 1 in 2 people in the UK will develop cancer at some point in their lives. The increased risk is primarily due to more people living into older age, when cancer is more common.
Researchers at Ohio State University identified three genes that enable glioblastoma stem-like cells to survive radiation therapy. MELK and EZH2 proteins form a complex that drives EZH2 expression, promoting tumor development and progression.
A study reveals children with 'biallelic mismatch repair deficiency' (bMMRD) experience a rapid wave of genetic mutations, dubbed the 'great flood', which causes aggressive cancer. The research identifies a previously undiscovered mechanism for cancer progression and potential targets for treatment.
New review highlights advances in image-guided surgery using fluorescence imaging to improve cancer detection and patient survival. Innovative strategies in low-income countries, such as mosquito net repairs and task redistribution, offer lessons for high-income countries.
Researchers at Moffitt Cancer Center discovered six microRNAs that can distinguish between high-risk and low-risk pancreatic lesions, offering a promising biomarker for early detection. This finding may lead to the development of a microRNA-based blood test to aid in predicting disease severity and foster new prevention strategies.
A retrospective cohort study found that metformin use was associated with a decreased risk of lung cancer in diabetic patients who had never smoked. Nonsmokers taking metformin for five years or longer showed a 52% reduction in lung cancer risk, but this finding was not statistically significant.
A new study published in Diabetologia found that cancer patients with diabetes have significantly lower medication adherence rates compared to those without diabetes. The research revealed that the type and stage of cancer had a significant impact on medication adherence, with more advanced cancers resulting in substantially lower rates.
The GW Cancer Institute will launch a yearlong study to gather key information about barriers encountered by patients with cancer, create evaluation tools for patient navigation at the community level, and translate research findings for practice-based audiences.
A survey of 364 medical journalists found that direct contact with physicians is the most reliable source of information for creating accurate cancer news. Medical journalists also rely on social media and personal connections to support their research, highlighting the need for responsible healthcare reporting.
Patients with a history of smoking have increased risks of cancer relapse, side effects, and death from prostate cancer, according to a study published in BJU International. Smoking negatively affects prostate cancer health outcomes, particularly when treated with radiotherapy.
A targeted magnetic resonance/ultrasound fusion biopsy detected more high-risk prostate cancers and fewer low-risk cancers compared to standard biopsy. The study found that adding standard biopsy to targeted biopsy provided limited benefits in detecting additional high-risk tumors.
A team of scientists from Georgetown University and Virginia Tech developed a mathematical model to understand breast cancer cell decisions, revealing a key molecular component that determines resistance to antiestrogen therapy. The study found that interferon regulatory factor-1 (IRF1) promotes resistance to antiestrogens.
A new analysis found that women with breast cancer have poor knowledge about their illness, with minority patients less likely to know accurate information. The study highlights the need for patient education and provider awareness to improve informed treatment decisions and overall cancer care.
A Cancer Research UK study found that people who dismiss their symptoms as trivial or worry about wasting the doctor's time may delay cancer diagnosis. The study discovered that many individuals with red-flag cancer warning symptoms felt they didn't need medical attention, fearing it would be seen as a sign of weakness.
Researchers used denoising autoencoders to effectively extract key biological principles from breast cancer gene expression data, resulting in gene expression features that generalize across studies and represent important clinical factors.
A team of researchers has developed a platform to rapidly identify effective drug combinations for lung cancer patients with resistant tumors. The NFCR-supported study uses cells taken from patient tumors and treats them with various drug combinations to find the most effective treatments.
The American Society of Clinical Oncology (ASCO) announces its cancer Advance of the Year, four new treatments improving outlook for patients with chronic lymphocytic leukemia (CLL). New therapies include immunotherapy drugs and molecularly targeted drugs offering more effective treatment options.
The SPECTAcolor platform has successfully implemented across 19 European clinical centers, recruiting over 500 patients and providing high-quality biological materials. Preliminary analysis reveals mutations in key cancer biomarkers, including KRAS, NRAS, BRAF, PI3K, and mismatch repair.
Researchers found that inactive EGFR is involved in autophagy, a process where cells consume nonessential contents to survive. Cancer cells use this process to thrive under stressful conditions. Combining drugs that block autophagy with those that inactivate EGFR could be an effective way to treat cancers
Researchers developed a new technique called proximity ligation assays (PLA) to analyze protein complexes in cancer specimens, which may aid in patient treatment decisions. By focusing on the epidermal growth factor receptor (EGFR), they discovered that patients with high amounts of EGFR protein complexes had a better prognosis when tr...
Cancer experts will discuss how to work together to accelerate progress towards a cure, expand global access to prevention, treatment, and care. The World Economic Forum is the right platform to address the urgent need for bold action.
Patients with advanced stage IV colorectal cancer are having fewer surgeries, but still showing improved survival rates due to the advent of more effective chemotherapeutic options and biologic treatments. The median survival rate for these patients has increased from 8.6% in 1988 to 17.8% in 2009.
A clinical trial found that animal-assisted therapy significantly improved the emotional well-being and quality of life of adult cancer patients. The study, published in Journal of Community and Supportive Oncology, involved 37 patients who received daily visits from certified therapy dogs during their treatment.
A new study finds that many cancer survivors experience lingering problems affecting their quality of life, including physical issues and anxiety about recurrence. The study suggests that clinicians can develop tailored interventions to address these specific concerns.
A phase II clinical trial has demonstrated that sunitinib, an FDA-approved drug, provides unprecedented antitumor activity in thymic carcinoma, a rare and aggressive tumor of the thymus gland. The study found that disease control was achieved in over 90% of patients who had failed chemotherapy.
A study has identified a new signaling pathway that generates slowly proliferating, chemo-resistant cancer cells. This pathway may offer new avenues for reducing tumor heterogeneity and improving treatment outcomes.
A study by University of Central Florida social work professor Mary Ann Burg found that cancer survivors often experience unmet needs, including physical problems like sexual dysfunction and anxiety about recurrence. The study analyzed responses from an American Cancer Society survey of 1,514 cancer survivors.
A new use of an existing antibody cocktail has been confirmed to provide key information about tumor recurrence in head and neck cancer patients. The ProExC cocktail allows pathologists to differentiate between true pre-neoplasia and reactive biopsies, enabling surgeons to make informed decisions about therapeutic interventions.
Researchers at Dartmouth Hitchcock's Norris Cotton Cancer Center developed a prognostic test for E2F4 in ER+ breast cancer, significantly predicting patient outcome regardless of treatment status. The test identifies patients who should receive aggressive follow-up treatment.
Researchers found that up to a quarter of patients with bowel cancer who have a family history could have their cancer caused by genetic mutations identified through gene testing. This could lead to improved diagnosis, treatment, and early detection for both the patient and their relatives.
Researchers have identified a novel cellular biomarker that can determine if a tumor has a potentially lethal mutation in the p53 protein, which is often referred to as the 'guardian of the genome'. The new biomarker can be used to assess p53 status in as little as 15 minutes.
Scientists discovered a small molecule, 6-thiodG, that can stop cancer cell growth and shrink tumors in mice. The compound works by disrupting the normal way cells maintain telomere length, triggering cell death.
A clinical trial combining stereotactic body radiation therapy with erlotinib improved overall and progression-free survival times for stage 4 lung cancer patients. The treatment combination increased survival rates by more than doubling, from 6-9 months to 20 months.
A recent study by UT Southwestern Medical Center researchers confirms that whole-genome sequencing can successfully identify cancer-related mutations in patients. The method was used to analyze the genomes of 258 cancer patients, detecting nearly 90% of clinically identified mutations and discovering additional cancer gene mutations.
A new study published in the Journal of Clinical Oncology found that the risk of developing leukemia after radiation therapy or chemotherapy for early-stage breast cancer is twice as high as previously reported. The study analyzed data from 20,063 breast cancer patients and found a cumulative risk of 0.5 percent.
A large study found that laparoscopic radical cystectomy leads to reliable cancer control even years after surgery, with 66% of patients free from recurrence after 5 years. The minimally invasive procedure can be as safe as open surgery for cancer control, supporting its use in bladder cancer management
University of Michigan researchers devise a reliable way to grow cancer cells from patients outside the body for study, increasing success rate to over 73% and opening doors to tailored therapies. The new technique could enable doctors to track cancer progression in real-time, making treatment decisions more informed.
Scientists have discovered that hydrogen peroxide is a key regulator of cellular functions, transmitting signals by oxidizing specific proteins. This discovery challenges previous assumptions and opens new avenues for understanding cancer development and progression.